S66 — Star Combo Pharma Cashflow Statement
0.000.00%
- AU$18.91m
- AU$5.09m
- AU$24.45m
Annual cashflow statement for Star Combo Pharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | Interim Report | ARS |
| Standards: | AAS | AAS | AAS | AAS | AAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.541 | 0.128 | 0.261 | 0.429 | 0.655 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.534 | 1.88 | -0.316 | 11.9 | 3.28 |
| Capital Expenditures | -7.29 | -2.73 | -1.44 | -0.394 | -2.45 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 4.05 | -0.5 | 1.3 | -9.33 | 0.433 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.24 | -3.23 | -0.137 | -9.72 | -2.02 |
| Financing Cash Flow Items | — | -0.201 | -0.207 | -0.202 | -0.21 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.169 | -0.053 | -0.371 | -0.795 | -0.941 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.88 | -1.41 | -0.824 | 1.43 | 0.315 |